Executive Summary: Cancer Therapeutics: The Worldwide Market , 2nd Edition (Related Reports)

Executive Summary: Cancer Therapeutics: The Worldwide Market , 2nd Edition


February 1, 2007
8 Pages - SKU: KLE1467850
License type:
Online Download      US $500.00
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017
3/27/2014 | published by: GlobalData
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on  |  read more...
$5,995.00
Malignant Mesothelioma Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This  |  read more...
$2,500.00
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide
4/1/2014 | published by: Renub Research
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Cervical Cancer Test Market Overview Cervical cancer is one of the deadliest cancers  |  read more...
$1,490.00
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Penile Cancer Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Penile Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2014 provides data on the Penile Cancer clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00